Bausch + Lomb Corporation (BLCO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bausch + Lomb Corporation (BLCO:NYSE), powered by AI.

Current Price
$15.08
P/E Ratio
-14.8
Market Cap
5.3B
Sector
Healthcare
What is the Bausch + Lomb Corporation stock price forecast?

Bausch + Lomb Corporation is currently trading at $15.08. View real-time AI analysis on Alpha Lenz.

What is Bausch + Lomb Corporation insider trading activity?

View the latest insider trading data for Bausch + Lomb Corporation on Alpha Lenz.

What is Bausch + Lomb Corporation's P/E ratio?

Bausch + Lomb Corporation's P/E ratio is -14.8.

Bausch + Lomb Corporation

NYSE · BLCO
$15.08-0.21(-1.37%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Bausch + Lomb Corporation's future dividend policy...
Alpha Chat Insight

Bausch + Lomb Corporation trades at a P/E of -14.8 (undervalued) with modest ROE of -5.6%. 3Y revenue CAGR of 10.6% highlights clear growth momentum.

Ask for details

Company Overview

Bausch + Lomb Corporation, a leading health care company, primarily focuses on eye health products. The corporation specializes in the development, manufacture, and marketing of a comprehensive range of contact lenses, lens care products, ophthalmic pharmaceuticals, and surgical devices, all designed to improve sight and enhance related health outcomes. Bausch + Lomb plays a crucial role in the vision care industry, impacting both everyday consumers and medical professionals by providing innovative solutions for vision correction and eye health. The company's offerings cater to diverse markets, including prescription eyewear, over-the-counter eye drops, and refractive laser systems used in medical facilities. Headquartered in Rochester, New York, Bausch + Lomb's commitment to advancing eye health is evident through its extensive research and development initiatives, which continually push the boundaries of eye care technology and treatment options. Through a strategic global presence, Bausch + Lomb significantly contributes to the eye health sector, addressing the growing demand for reliable and advanced vision care products worldwide.

CEOMr. Brenton L. Saunders J.D.
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees13,500

Company Statistics

FY 2025

Profile

$5.34BMarket Cap
$5.10BRevenue
0.00Shares Out
13,500Employees

Margins

59.81%Gross
12.17%EBITDA
3.69%Operating
-6.21%Pre-Tax
-6.90%Net

Valuation

-14.82P/E
0.83P/B
1.05EV/Sales
16.27EV/EBITDA
-80.84P/FCF

Growth (CAGR)

10.62%Rev 3Yr
8.38%Rev 5Yr
-4.96%Op Inc 3Yr
-6.98%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-2.56%ROA
-5.57%ROE
0.76%ROIC

Financial Health

$383.00MCash & Cash Equivalents
$7.12BNet Debt
115.09%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Bausch + Lomb Corporation (ticker: BLCO) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 13,500 employees. Market cap is $5.3B.

The current price is $15.08 with a P/E ratio of -14.82x and P/B of 0.83x.

ROE is -5.57% and operating margin is 3.69%. Annual revenue is $5.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Bausch + Lomb Corporation (BLCO) Stock Forecast 2026 $15.08 — Price, Financials & Analyst Targets | Alpha Lenz